BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38773451)

  • 1. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
    Xiang D; Fu L; Yang Y; Liu C; He Y
    BMC Gastroenterol; 2024 May; 24(1):178. PubMed ID: 38773451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma.
    Fu J; Li Y; Li Z; Li N
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29717027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
    Yi X; Yu S; Bao Y
    Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
    Xu C; Yan Z; Zhou L; Wang Y
    J Cancer Res Clin Oncol; 2013 Aug; 139(8):1417-24. PubMed ID: 23743582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang Z; Chen P; Xie H; Cao P
    Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
    Zhang J; Zhao Y; Yang Q
    Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
    Li Z; Mou L; Gao H; Zeng Y; Tang X; Deng X; Pu Z; Ni Y; Zhan Y
    Medicine (Baltimore); 2019 Aug; 98(32):e16725. PubMed ID: 31393380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.
    Zhou Y; Yin X; Ying J; Zhang B
    BMC Cancer; 2012 Jan; 12():17. PubMed ID: 22244200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
    Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
    Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
    Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
    Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
    PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma.
    Jeng JE; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Tumour Biol; 2014 Apr; 35(4):3689-98. PubMed ID: 24375326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
    Li JJ; Lv Y; Ji H
    PeerJ; 2022; 10():e14303. PubMed ID: 36348665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
    Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
    PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis.
    Zhou JM; Wang T; Zhang KH
    Medicine (Baltimore); 2021 Oct; 100(43):e27673. PubMed ID: 34713864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis.
    Fang YS; Wu Q; Zhao HC; Zhou Y; Ye L; Liu SS; Li XX; Du WD
    Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):1065-1076. PubMed ID: 33691550
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
    Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.